Literature DB >> 10854161

Identification by mass spectroscopy of three major early proteins associated with virosomes in vaccinia virus-infected cells.

A Murcia-Nicolas1, G Bolbach, J C Blais, G Beaud.   

Abstract

Virosomes are cytoplasmic sites of replication of vaccinia virus DNA and were prepared from virus-infected HeLa cells. The early virosomal proteins were 35S-labelled and SDS polyacrylamide gel electrophoresis revealed the presence of three major early 35S-labelled proteins of 34, 24 and 45 kDa. The masses of molecules present in the 34 and 24 kDa proteins were measured by the convenient and sensitive MALDI TOF mass spectroscopy technique. Identification of the three virosomal proteins was carried out by MALDI mass spectroscopy of corresponding tryptic digests. For each protein at least 13 measured masses matched, within less than 0.1 Da, calculated tryptic peptides of the vaccinia virus proteins H5R (34 kDa), E3L (24 kDa) and E5R (45 kDa). In addition, virosomes contained several structural proteins from the infecting virus and a 45 kDa keratin-related protein. This work demonstrates directly that the abundant early vaccinia virus proteins H5R, E3L and E5R are associated with the virosomes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10854161     DOI: 10.1016/s0168-1702(98)00114-2

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  10 in total

1.  BEN: a novel domain in chromatin factors and DNA viral proteins.

Authors:  Saraswathi Abhiman; Lakshminarayan M Iyer; L Aravind
Journal:  Bioinformatics       Date:  2008-01-18       Impact factor: 6.937

2.  A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription.

Authors:  Steven G Cresawn; Richard C Condit
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

Review 3.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

4.  Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA.

Authors:  Abigail M Druck Shudofsky; Janice Elaine Y Silverman; Debasish Chattopadhyay; Robert P Ricciardi
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

5.  Identification of inhibitors that block vaccinia virus infection by targeting the DNA synthesis processivity factor D4.

Authors:  Manunya Nuth; Lijuan Huang; Yih Ling Saw; Norbert Schormann; Debasish Chattopadhyay; Robert P Ricciardi
Journal:  J Med Chem       Date:  2011-04-19       Impact factor: 7.446

Review 6.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

7.  Genome scale patterns of recombination between coinfecting vaccinia viruses.

Authors:  Li Qin; David H Evans
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

8.  Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes.

Authors:  Erika Assarsson; Jason A Greenbaum; Magnus Sundström; Lana Schaffer; Jennifer A Hammond; Valerie Pasquetto; Carla Oseroff; R Curtis Hendrickson; Elliot J Lefkowitz; David C Tscharke; John Sidney; Howard M Grey; Steven R Head; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-01       Impact factor: 11.205

9.  Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins.

Authors:  Jennifer D Yoder; Tsefang S Chen; Cliff R Gagnier; Srilakshmi Vemulapalli; Claudia S Maier; Dennis E Hruby
Journal:  Virol J       Date:  2006-03-01       Impact factor: 4.099

10.  The vaccinia virus K7 protein promotes histone methylation associated with heterochromatin formation.

Authors:  Wondimagegnehu M Teferi; Megan A Desaulniers; Ryan S Noyce; Mira Shenouda; Brittany Umer; David H Evans
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.